Stoke Therapeutics Inc (NASDAQ:STOK)

14.58
BATS BZX Real-Time Price
As of 10:13am ET
 +0.43 / +3.04%
Today’s Change
9.55
Today|||52-Week Range
34.83
-39.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2018
Quarter 1
2019

--

--
Operating ActivitiesNet Income / Starting Line-1.9M-5.7M----
 
 
 
Depreciation32.0K80.0K----
 
 
 
Total Other Cash Flow4.0K184.0K----
 
 
 
Funds From Operations-1.9M-5.5M----
 
 
 
Funds From/For Other Operating Expenses113.0K1.1M----
 
 
 
Net Cash Flow - Operating Activities-2.0M-6.5M----
 
 
 
 
InvestingCapital Expenditures-26.0K-92.0K----
 
 
 
Fixed Asset Disposal0.002.0K----
 
 
Net Cash Flow Investing-26.0K-90.0K----
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings0.000.00------
Long Term Debt Reduction0.000.00------
Net Proceeds Stock Sale12.4M-67.0K----
 
 
 
Common Preferred Redeemed0.000.00------
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.00------
Other Uses - Financing1.0K1.0K----
 
 
 
Net Cash Flow - Financing12.4M-68.0K----
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash10.4M-6.7M----